I know. They won't get anywhere in the U.S., very likely. They seem to plan to be active abroad, especially in South America.
But probably they don't want their investors here to consider that. Or to consider what a "course" that costs only $650 is likely to do for unlucky patients.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.